微血管并发症病程与负担对1型糖尿病死亡率的影响:观察性临床队列研究
该观察性临床队列纳入2001—2013年在Steno糖尿病中心就诊的3828例1型糖尿病患者,随访26665人年共503例死亡。调整多种混杂因素后,糖尿病肾病和神经病变与死亡率升高独立相关,视网膜病变未见关联;多种并发症的死亡风险未超过各单一并发症风险的叠加,并发症病程对死亡率影响仅边际。
要点
- 糖尿病肾病和神经病变是1型糖尿病死亡的强独立风险标志。
- 视网膜病变未显示与死亡率升高相关。
- 多种微血管并发症的死亡风险不超过各单一并发症风险的叠加。
核心结论
- 神经病变和糖尿病肾病是1型糖尿病死亡的强独立风险标志,视网膜病变未见死亡率升高证据。
- 多种并发症的死亡风险未超过各单一并发症分别带来的风险之和。
- 微血管并发症的病程对死亡率仅有边际影响。
研究设计与样本
- 观察性临床队列研究,纳入2001—2013年在Steno糖尿病中心就诊的3828例1型糖尿病患者。
- 随访共26665人年,期间发生503例死亡。
- 采用泊松模型按并发症负担建模死亡率。
主要发现
- 与无微血管并发症者相比,糖尿病肾病患者的死亡率比值为2.20(95%CI 1.79, 2.69)。
- 神经病变患者的死亡率比值为1.72(95%CI 1.39, 2.12)。
- 视网膜病变患者的死亡率比值为1.02(95%CI 0.77, 1.37)。
- 上述比值均调整日历时间、年龄、糖尿病病程、性别、HbA1c、LDL胆固醇、BMI、吸烟状态、收缩压、降压和降脂药物使用及心血管疾病状态。
- 神经病变和糖尿病肾病确诊后死亡率比值立即升高;神经病变和视网膜病变的死亡率比值与病程无关,糖尿病肾病相关死亡率约3年后达稳定水平。
临床怎么用
- 对1型糖尿病患者应重视糖尿病肾病和神经病变的筛查与评估,因其与死亡率升高独立相关。
- 视网膜病变的存在不应单独作为死亡风险升高的判断依据。
- 多种微血管并发症并存时,死亡风险可按各并发症分别评估,未见额外叠加效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The role of burden and duration of multiple microvascular complications on mortality rate has not been explored in detail in type 1 diabetes. Taking complication burden and time-updated duration into account we aimed to quantify mortality rate in individuals with and without microvascular complications. METHODS: This observational clinical cohort included 3828 individuals with type 1 diabetes attending the Steno Diabetes Center Copenhagen in 2001-2013. We used information on mortality and detailed clinical measures of microvascular complications from electronic patient records. Poisson models were used to model mortality rates according to complication burden. RESULTS: During 26,665 person-years of follow-up, 503 deaths occurred. Compared with individuals without microvascular complications, the mortality rate ratio was 2.20 (95% CI 1.79, 2.69) for individuals with diabetic kidney disease, 1.72 (95% CI 1.39, 2.12) for individuals with neuropathy and 1.02 (95% CI 0.77, 1.37) for individuals with retinopathy, all adjusted for calendar time (year/month/day), age, duration of diabetes, sex, HbA1c, LDL-cholesterol, BMI, smoking status, systolic blood pressure, use of antihypertensive and lipid-lowering medication, and cardiovascular disease status. In individuals with two complications or more, the risk of mortality did not exceed the combined risk from each individual complication. Mortality rate ratios increased immediately after diagnosis of neuropathy and diabetic kidney disease. Mortality rate ratios were independent of the duration of neuropathy and retinopathy, while the mortality rate associated with diabetic kidney disease reached a stable level after approximately 3 years. CONCLUSIONS/INTERPRETATION: Neuropathy and diabetic kidney disease are strong and independent risk markers of mortality in type 1 diabetes, whereas no evidence of higher mortality rate was found for retinopathy. We found no indication that the mortality risk with multiple complications exceeds the risk conferred by each complication separately. The duration spent with microvascular complications had only a marginal effect on mortality.
引用
- Bjerg L, Hulman A, Carstensen B, et al. Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study. Diabetologia. 2019. PMID: 30649599. doi:10.1007/s00125-019-4812-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。